A new study suggests that people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) may live longer ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

Breakthrough research could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Proteins play a central role in virtually every disease. They are the building blocks of life, serving as essential ...

In 2025, newly-designed clinical trials for people with cancer are providing new options and hope for patients and their ...

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 ...

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...